Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

23

Revenue 2014

Biogen Idec

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Biogen Idec's 2013 Oncology and CNS sales performance.

Samsung deal with Takeda looks beyond biosimilars

Samsung deal with Takeda looks beyond biosimilars

hoped. For Samsung Bioepis - a joint venture between Samsung and Biogen set up five years ago - the deal takes it from the relatively less risky path of developing copies of

Biogen and IXICO expands Assessa

Biogen and IXICO expands Assessa Biogen and IXICO expands Assessa. The PML digital platform will include pharmacoviglance reporting. ... Biogen invest a total of £1.5m in the project, which is currently being piloted in five EU countries.

Managing medication non-adherence

Managing medication non-adherence efficacious. Biogen has been playing in this space for a few years now and conducted a clinical trial with PatientsLikeMe that showed how people living with multiple sclerosis (MS) can use

Biogen develops quantum computing-based app to speed drug discovery

Biogen develops quantum computing-based app to speed drug discovery Biogen develops quantum computing-based app to speed drug discovery. Collaborates with Accenture and 1QBit in neurological diseases. ... Developed by Biogen, Accenture and Canadian software firm 1QBit, the app aims to dramatically cut costs and time to

Warning sounded on pharma's long-term sales prospects

Warning sounded on pharma's long-term sales prospects Biogen's aducanumab for Alzheimer's disease - although clearly a high-risk candidate - and Johnson &Johnson's prostate cancer therapy apalutamide, which is due to be filed later this year.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
StratX

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

The_Pharma_Wars_Series.png
The Pharma Wars Series
The future galaxy is complex. Where markets are more competitive and customers more segmented, you’ve got to be smarter. But not only smarter, the Jedi today needs to be everywhere...
What pharma marketers can learn from growth hacking?
Growth hackers instinctively blend technical skills with creative thinking...
Medicines for Europe
The sound of silence puts the squeeze on generics and biosimilars
Medicines for Europe vows to get governments talking to realise potential...

Infographics